Rankings
▼
Calendar
DBVT FY 2022 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena
DBVT
DBV Technologies S.A.
$560M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
-15.9% YoY
Gross Profit
-$15M
-322.9% margin
Operating Income
-$97M
-2013.1% margin
Net Income
-$96M
-2006.3% margin
EPS (Diluted)
$-6.20
Cash Flow
Operating Cash Flow
-$56M
Free Cash Flow
-$56M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$247M
Total Liabilities
$52M
Stockholders' Equity
$194M
Cash & Equivalents
$209M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$6M
-15.9%
Gross Profit
-$15M
-$4M
-334.8%
Operating Income
-$97M
-$99M
+2.0%
Net Income
-$96M
-$98M
+1.5%
← Q4 2021
All Quarters
Q1 2022 →